Recombinant adenovirus expressing Von Hippel-Lindau-mediated cell cycle arrest is associated with the induction of cyclin-dependent kinase inhibitor p27Kip1

被引:50
|
作者
Kim, M [1 ]
Katayose, Y [1 ]
Li, QD [1 ]
Rakkar, ANS [1 ]
Li, ZW [1 ]
Hwang, SG [1 ]
Katayose, D [1 ]
Trepel, J [1 ]
Cowan, KH [1 ]
Seth, P [1 ]
机构
[1] NCI, Med Branch, NIH, Bethesda, MD 20892 USA
基金
美国国家卫生研究院;
关键词
VHL; p27(Kip1); adenovirus; cell cycle; gene therapy; cyclin-dependent kinase;
D O I
10.1006/bbrc.1998.9839
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A recombinant adenovirus containing the Von Hippel-Lindau (VHL) cDNA was constructed (AdVHL) and used to investigate the function of this tumor suppressor gene. Exposure of renal and breast cancer cell lines to AdVHL resulted in high levels of VHL mRNA and protein. AdVHL infection resulted in G1 cell cycle arrest and growth inhibition of renal and breast cancer cell lines. AdVHL-mediated cell cycle arrest was associated with induction of the cyclin-dependent kinase inhibitor (CDKI) p27(Kip1) and inhibition of CDK2 and cyclinB1-dependent cdc2 activities. Nuclear run-on analyses and actinomycin D inhibition studies indicate that the induction of p27(Kip1) RNA by VHL is mediated at least in part through an increase in p27(Kip1) mRNA synthesis. Furthermore, [S-35]methionine pulse-chase studies indicate that the increase in p27(Kip) expression is also regulated through posttranscriptional control mechanisms. These studies support a novel concept that the tumor suppressor gene VHL controls cell cycle progression by regulation of p27(Kip1) at both the mRNA and protein levels. (C) 1998 Academic Press.
引用
收藏
页码:672 / 677
页数:6
相关论文
共 50 条
  • [1] TGFβ prevents proteasomal degradation of the cyclin-dependent kinase inhibitor p27kip1 for cell cycle arrest
    Lecanda, Jon
    Ganapathy, Vidya
    D'Aquino-Ardalan, Christine
    Evans, Brad
    Cadacio, Caprice
    Ayala, Aidee
    Gold, Leslie I.
    CELL CYCLE, 2009, 8 (05) : 742 - 756
  • [2] Modulation of apoptosis by the cyclin-dependent kinase inhibitor p27Kip1
    Hiromura, K
    Pippin, JW
    Fero, ML
    Roberts, JM
    Shankland, SJ
    JOURNAL OF CLINICAL INVESTIGATION, 1999, 103 (05): : 597 - 604
  • [3] The cyclin-dependent kinase inhibitor p27KIP1 is mandatory for tolerance induction in vivo.
    Li, LQ
    Berezovskaya, A
    Boussiotis, VA
    BLOOD, 2005, 106 (11) : 227A - 227A
  • [4] Cyclin-dependent kinase inhibitor p27Kip1 expression and interaction with other cell cycle associated proteins in mammary carcinoma
    Gillett, CE
    Smith, P
    Peters, G
    Lu, X
    Barnes, DM
    JOURNAL OF PATHOLOGY, 1999, 187 (02): : 200 - 206
  • [5] Expression of cyclin-dependent kinase inhibitor p27kip1 in malignant lymphomas
    Oh, YH
    Park, CK
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2000, 15 (04) : 399 - 406
  • [6] Modulation of astrocyte proliferation by cyclin-dependent kinase inhibitor p27Kip1
    Koguchi, K
    Nakatsuji, Y
    Nakayama, K
    Sakoda, S
    GLIA, 2002, 37 (02) : 93 - 104
  • [7] The accumulation of cyclin-dependent kinase inhibitor p27kip1 is a primary response to staurosporine and independent of G1 cell cycle arrest
    Nishi, K
    Schnier, JB
    Bradbury, EM
    EXPERIMENTAL CELL RESEARCH, 1998, 243 (02) : 222 - 231
  • [8] Mantle cell lymphomas lack expression of p27kip1, a cyclin-dependent kinase inhibitor
    Quintanilla-Martinez, L
    Thieblemont, C
    Fend, F
    Kumar, S
    Pinyol, M
    Campo, E
    Jaffe, ES
    Raffeld, M
    AMERICAN JOURNAL OF PATHOLOGY, 1998, 153 (01): : 175 - 182
  • [9] BRCA1 transactivates the cyclin-dependent kinase inhibitor p27Kip1
    Elizabeth A Williamson
    Farnaz Dadmanesh
    H Phillip Koeffler
    Oncogene, 2002, 21 : 3199 - 3206
  • [10] BRCA1 transactivates the cyclin-dependent kinase inhibitor p27Kip1
    Williamson, EA
    Dadmanesh, F
    Koeffler, HP
    ONCOGENE, 2002, 21 (20) : 3199 - 3206